Search:
Tokushima UniversityGraduate School of Biomedical Sciences医学域先端医学教育研究プロジェクト
Tokushima UniversityGraduate School of Biomedical Sciences医学域Medical ScienceInternal MedicineDepartment of Psychiatry
Tokushima UniversityUniversity HospitalClinical DivisionDepartment of Neurosurgery, Psychiatry and AnesthesiologyPsychiatry
Tokushima UniversityGraduate School of Medical SciencesMedical ScienceCourse of Integrated Brain Sciences
Tokushima UniversityUniversity HospitalClinical DivisionDepartment of Neurosurgery, Psychiatry and AnesthesiologyPsychosomatic Medicine
Tokushima UniversityFaculty of MedicineSchool of MedicineCourse of Integrated Brain SciencesPsychiatry
(Files for researchmap) [PDF manual] [Auto-propagate to researchmap]

Research

Field of Study

Medicine

Subject of Study

Book / Paper

Book:

1. Masahito Nakataki :
診療と検査,
株式会社 中外医学社, Jan. 2021.
2. Masahito Nakataki :
CHAPTER 11 てんかん,
株式会社 中外医学社, Jun. 2016.
3. Masahito Nakataki and Shinya Watanabe :
てんかん,
株式会社 中外医学社, Jun. 2015.
4. Masahito Nakataki :
てんかん,
株式会社 中外医学社, Mar. 2011.

Academic Paper (Judged Full Paper):

1. Chise Ueoka, Masahito Nakataki, Yoshinori Ueoka, Atsuko Miyazaki, Saki Taniguchi and Tetsuro Ohmori :
An attempt to analyze the longitudinal psychological state of cancer patients in the active treatment stage.,
The Journal of Medical Investigation : JMI, Vol.68, No.1.2, 148-153, 2021.
(Tokushima University Institutional Repository: 115935,   DOI: 10.2152/jmi.68.148,   PubMed: 33994460)
2. Chigusa Uchiumi, Hiroshi Kato, Motohiro Ishida, Masahito Nakataki and Tetsuro Ohmori :
Peritraumatic reactions, PTSD symptoms, and pain : A study of train disasters in Japan.,
The Journal of Medical Investigation : JMI, Vol.68, No.1.2, 85-89, 2021.
(Tokushima University Institutional Repository: 115626,   DOI: 10.2152/jmi.68.85,   PubMed: 33994485)
3. Ryoma Morigaki, Ryosuke Miyamoto, Hideo Mure, Koji Fujita, Taku Matsuda, Yoko Yamamoto, Masahito Nakataki, Tetsuya Okahisa, Yuki Matsumoto, Kazuhisa Miyake, Nobuaki Yamamoto, Ryuji Kaji, Yasushi Takagi and Satoshi Goto :
Can Pallidal Deep Brain Stimulation Rescue Borderline Dystonia? Possible Coexistence of Functional (Psychogenic) and Organic Components.,
Brain Sciences, Vol.10, No.9, 636, 2020.
(Tokushima University Institutional Repository: 116502,   DOI: 10.3390/brainsci10090636,   PubMed: 32942724)
4. Yukiko Tomioka, Makoto Kinoshita, Hidehiro Umehara, Tomohiko Nakayama, Shinya Watanabe, Masahito Nakataki, Shusuke Numata and Tetsuro Ohmori :
Association between serum folate levels and schizophrenia based on sex.,
Psychiatry and Clinical Neurosciences, Vol.74, No.9, 466-471, 2020.
(Tokushima University Institutional Repository: 115397,   DOI: 10.1111/pcn.13074,   PubMed: 32445495)
5. D Koshiyama, M Fukunaga, N Okada, K Morita, K Nemoto, K Usui, H Yamamori, Y Yasuda, M Fujimoto, N Kudo, H Azechi, Y Watanabe, N Hashimoto, H Narita, I Kusumi, K Ohi, T Shimada, Y Kataoka, M Yamamoto, N Ozaki, G Okada, Y Okamoto, K Harada, K Matsuo, H Yamasue, O Abe, R Hashimoto, T Takahashi, T Hori, Masahito Nakataki, T Onitsuka, L Holleran, N Jahanshad, TGM Erp van, J Turner, G Donohoe, PM Thompson, K Kasai and R Hashimoto :
White matter microstructural alterations across four major psychiatric disorders: mega-analysis study in 2937 individuals.,
Molecular Psychiatry, Vol.25, No.4, 883-895, 2020.
(Tokushima University Institutional Repository: 115601,   DOI: 10.1038/s41380-019-0553-7,   PubMed: 31780770)
6. S Schwab, A Federspiel, Y Morishima, Masahito Nakataki, W Strik, R Wiest, M Heinrichs, D Quervain de and LM Soravia :
Glucocorticoids and cortical decoding in the phobic brain.,
Psychiatry Research. Neuroimaging, Vol.31, No.300, 111066, 2020.
(DOI: 10.1016/j.pscychresns.2020.111066,   PubMed: 32244111)
7. Takeo Tominaga, Masahito Tomotake, Tomoya Takeda, Yoshinori Ueoka, Tsunehiko Tanaka, Shinya Watanabe, Naomi Kameoka, Masahito Nakataki, Shusuke Numata, Yumiko Izaki, Satsuki Sumitani, Hiroko Kubo, Yasuhiro Kaneda and Tetsuro Ohmori :
Predictors of life skills in people with schizophrenia,
The Journal of Medical Investigation : JMI, Vol.67, No.1,2, 75-82, 2020.
(Tokushima University Institutional Repository: 114756,   DOI: 10.2152/jmi.67.75,   PubMed: 32378622,   Elsevier: Scopus)
8. Chikako Kane, Masahito Tomotake, Hamatani Sayo, Shin-ichi Chiba, Naomi Kameoka, Shinya Watanabe, Masahito Nakataki, Shusuke Numata and Tetsuro Ohmori :
Clinical factors influencing resilience in patients with anorexia nervosa,
Neuropsychiatric Disease and Treatment, Vol.15, 391-395, 2019.
(Tokushima University Institutional Repository: 115649,   DOI: 10.2147/NDT.S190725,   PubMed: 30787613,   Elsevier: Scopus)
9. Tomoya Takeda, Masahito Nakataki, Masashi Ohta, S Hamatani, K Matsuura, R Yoshida, Naomi Kameoka, Takeo Tominaga, Hidehiro Umehara, Makoto Kinoshita, Shinya Watanabe, Shusuke Numata, Satsuki Sumitani and Tetsuro Ohmori :
Negative and positive self-thoughts predict subjective quality of life in people with schizophrenia.,
Neuropsychiatric Disease and Treatment, Vol.15, 293-301, 2019.
(Tokushima University Institutional Repository: 113356,   DOI: 10.2147/NDT.S190381,   PubMed: 30718955,   Elsevier: Scopus)
10. Makoto Kinoshita, Masahito Nakataki, Ryoma Morigaki, Satsuki Sumitani, Satoshi Goto, Ryuji Kaji and Tetsuro Ohmori :
Turning on the Left Side Electrode Changed Depressive State to Manic State in a Parkinson's Disease Patient Who Received Bilateral Subthalamic Nucleus Deep Brain Stimulation: A Case Report.,
Clinical Psychopharmacology and Neuroscience, Vol.16, No.4, 494-496, 2018.
(Tokushima University Institutional Repository: 114301,   DOI: 10.9758/cpn.2018.16.4.494,   PubMed: 30466222,   Elsevier: Scopus)
11. Takeo Tominaga, Masahito Tomotake, Tomoya Takeda, Yoshinori Ueoka, Tsunehiko Tanaka, Shinya Watanabe, Naomi Kameoka, Masahito Nakataki, Shusuke Numata, Yumiko Izaki, Satsuki Sumitani, hiroko Kubo, Yasuhiro Kaneda and Tetsuro Ohmori :
Relationship between social and cognitive functions in people with schizophrenia,
Neuropsychiatric Disease and Treatment, Vol.14, 2215-2224, 2018.
(Tokushima University Institutional Repository: 114525,   DOI: 10.2147/NDT.S171207,   PubMed: 30214211,   Elsevier: Scopus)
12. LM Soravia, S Schwab, N Weber, Masahito Nakataki, R Wiest, W Strik, M Heinrichs, D Quervain de and A. Federspiel :
Glucocorticoid administration restores salience network activity in patients with spider phobia.,
Depression and Anxiety, Vol.35, No.10, 925-934, 2018.
(DOI: 10.1002/da.22806,   PubMed: 30099829,   Elsevier: Scopus)
13. Masashi Ohta, Masahito Nakataki, Tomoya Takeda, Shusuke Numata, Takeo Tominaga, Naomi Kameoka, Hiroko Kubo, Makoto Kinoshita, K Matsuura, M Otomo, N Takeichi, Masafumi Harada and Tetsuro Ohmori :
Structural equation modeling approach between salience network dysfunction, depressed mood, and subjective quality of life in schizophrenia: an ICA resting-state fMRI study.,
Neuropsychiatric Disease and Treatment, Vol.14, 1585-1597, 2018.
(Tokushima University Institutional Repository: 113339,   DOI: 10.2147/NDT.S163132,   PubMed: 29942132,   Elsevier: Scopus)
14. Tomoya Takeda, Masahito Nakataki, Masashi Ohta, Sayo Hamatani, Kanae Matsuura and Tetsuro Ohmori :
Effect of cognitive function on jumping to conclusion in patients with schizophrenia.,
Schizophrenia Research. Cognition, Vol.12, 50-55, 2018.
(Tokushima University Institutional Repository: 115715,   DOI: 10.1016/j.scog.2018.04.002,   PubMed: 29928597,   Elsevier: Scopus)
15. Yukiko Tomioka, Shusuke Numata, Makoto Kinoshita, Hidehiro Umehara, Shinya Watanabe, Masahito Nakataki, Y Iwayama, T Toyota, M Ikeda, H Yamamori, S Shimodera, A Tajima, R Hashimoto, N Iwata, T Yoshikawa and Tetsuro Ohmori :
Decreased serum pyridoxal levels in schizophrenia: meta-analysis and Mendelian randomization analysis.,
Journal of Psychiatry & Neuroscience, Vol.43, No.3, 194-200, 2018.
(Tokushima University Institutional Repository: 114064,   DOI: 10.1503/jpn.170053,   PubMed: 29688875)
16. Masatoshi Inoshita, Hidehiro Umehara, Shinya Watanabe, Masahito Nakataki, Makoto Kinoshita, Yukiko Tomioka, Atsushi Tajima, Shusuke Numata and Tetsuro Ohmori :
Elevated peripheral blood glutamate levels in major depressive disorder.,
Neuropsychiatric Disease and Treatment, Vol.14, 945-953, 2018.
(Tokushima University Institutional Repository: 114063,   DOI: 10.2147/NDT.S159855,   PubMed: 29670355,   Elsevier: Scopus)
17. Hideo Mure, Ryoma Morigaki, Ryosuke Miyamoto, Masahito Nakataki, 岡久 哲也, Shinsuke Katoh, Ryuji Kaji, Yasushi Takagi, Shinji Nagahiro and Satoshi Goto :
Multi-disciplinary approach for dystonia patients by treatment with deep brain stimulation,
Functional Neurosurgery, Vol.57, 35-39, 2018.
(CiNii: 1571980079433795328)
18. Kristoffer Daniel Fehér, Masahito Nakataki and Yosuke Morishima :
Phase-Dependent Modulation of Signal Transmission in Cortical Networks through tACS-Induced Neural Oscillations.,
Frontiers in Human Neuroscience, Vol.11, 471, 2017.
(Tokushima University Institutional Repository: 114491,   DOI: 10.3389/fnhum.2017.00471,   PubMed: 29021749,   Elsevier: Scopus)
19. Kazuo Takiguchi, Akihito Uezato, Michio Itasaka, Hidenori Atsuta, Kenji Narushima, Naoki Yamamoto, Akeo Kurumaji, Makoto Tomita, Kazunari Oshima, Kosaku Shoda, Mai Tamaru, Masahito Nakataki, Mitsutoshi Okazaki, Sayuri Ishiwata, Yasuyoshi Ishiwata, Masato Yasuhara, Kunimasa Arima, Tetsuro Ohmori and Toru Nishikawa :
Association of schizophrenia onset age and white matter integrity with treatment effect of D-cycloserine: a randomized placebo-controlled double-blind crossover study.,
BMC Psychiatry, Vol.17, No.1, 249, 2017.
(Tokushima University Institutional Repository: 114062,   DOI: 10.1186/s12888-017-1410-3,   PubMed: 28701225,   Elsevier: Scopus)
20. Hiroko Kubo, Masahito Nakataki, Satsuki Sumitani, Junichi Iga, Shusuke Numata, Naomi Kameoka, Shinya Watanabe, Hidehiro Umehara, Makoto Kinoshita, Masatoshi Inoshita, Mai Tamaru, Masashi Ohta, Chiaki Nakayama-Yamauchi, Yasuhiro Funakoshi, Masafumi Harada and Tetsuro Ohmori :
1H-magnetic resonance spectroscopy study of glutamate-related abnormality in bipolar disorder.,
Journal of Affective Disorders, Vol.208, 139-144, 2017.
(Tokushima University Institutional Repository: 109987,   DOI: 10.1016/j.jad.2016.08.046,   PubMed: 27770643,   Elsevier: Scopus)
21. Masahito Nakataki, Leila M Soravia, Simon Schwab, Helge Horn, Thomas Dierks, Werner Strik, Roland Wiest, Markus Heinrichs, Dominique de J-F Quervain, Andrea Federspiel and Yosuke Morishima :
Glucocorticoid Administration Improves Aberrant Fear-Processing Networks in Spider Phobia.,
Neuropsychopharmacology, Vol.42, No.2, 485-494, 2017.
(DOI: 10.1038/npp.2016.207,   PubMed: 27644128,   Elsevier: Scopus)
22. LM Soravia, A Orosz, S Schwab, Masahito Nakataki, R Wiest and A Federspiel :
CBT reduces CBF: cognitive-behavioral therapy reduces cerebral blood flow in fear-relevant brain regions in spider phobia.,
Brain and Behavior, Vol.6, No.9, e00510, 2016.
(Tokushima University Institutional Repository: 115030,   DOI: 10.1002/brb3.510,   PubMed: 27688940)
23. Hidehiro Umehara, Shusuke Numata, Atsushi Tajima, Akira Nishi, Masahito Nakataki, Issei Imoto, Satsuki Sumitani and Tetsuro Ohmori :
Calcium Signaling Pathway Is Associated with the Long-Term Clinical Response to Selective Serotonin Reuptake Inhibitors (SSRI) and SSRI with Antipsychotics in Patients with Obsessive-Compulsive Disorder.,
PLoS ONE, Vol.11, No.6, e0157232., 2016.
(Tokushima University Institutional Repository: 110039,   DOI: 10.1371/journal.pone.0157232,   PubMed: 27281126,   Elsevier: Scopus)
24. LM Soravia, JS Witmer, S Schwab, Masahito Nakataki, T Dierks, R Wiest, K Henke, A Federspiel and K Jann :
Prestimulus default mode activity influences depth of processing and recognition in an emotional memory task.,
Human Brain Mapping, Vol.37, No.3, 924-932, 2016.
(DOI: 10.1002/hbm.23076,   PubMed: 26663662)
25. Shinya Watanabe, Junichi Iga, Akira Nishi, Shusuke Numata, Makoto Kinoshita, K Kikuchi, Masahito Nakataki and Tetsuro Ohmori :
Microarray analysis of global gene expression in leukocytes following lithium treatment.,
Human Psychopharmacology, Vol.29, No.2, 190-198, 2014.
(Tokushima University Institutional Repository: 106183,   DOI: 10.1002/hup.2381,   PubMed: 24590544,   Elsevier: Scopus)
26. Makoto Kinoshita, Shusuke Numata, Atsushi Tajima, S Shimodera, S Ono, A Imamura, Junichi Iga, Shinya Watanabe, Kumiko Kikuchi, Hiroko Kubo, Masahito Nakataki, Satsuki Sumitani, Issei Imoto, Y Okazaki and Tetsuro Ohmori :
DNA Methylation Signatures of Peripheral Leukocytes in Schizophrenia.,
NeuroMolecular Medicine, Vol.Mar;15, No.1, 95-101, 2013.
(Tokushima University Institutional Repository: 106144,   DOI: 10.1007/s12017-012-8198-6,   PubMed: 22961555,   Elsevier: Scopus)
27. Shinya Watanabe, Junichi Iga, Shusuke Numata, Masahito Nakataki, Toshihito Tanahashi, Mitsuo Itakura and Tetsuro Ohmori :
Association Study of Fat-mass and Obesity-associated Gene and Body Mass Index in Japanese Patients with Schizophrenia and Healthy Subjects.,
Clinical Psychopharmacology and Neuroscience, Vol.10, No.3, 185-189, 2012.
(DOI: 10.9758/cpn.2012.10.3.185,   PubMed: 23431037)
28. Tsunehiko Tanaka, Masahito Tomotake, Yoshinori Ueoka, Yasuhiro Kaneda, Kyoko Taniguchi, Masahito Nakataki, Shusuke Numata, Shinya Tayoshi, Ken Yamauchi, Satsuki Sumitani, Takashi Ohmori, Shu-ichi Ueno and Tetsuro Ohmori :
Clinical correlates associated with cognitive dysfunction in people with schizophrenia.,
Psychiatry and Clinical Neurosciences, Vol.66, No.6, 491-498, 2012.
(DOI: 10.1111/j.1440-1819.2012.02390.x,   PubMed: 23066766)
29. Makoto Kinoshita, Masahito Nakataki, Satsuki Sumitani and Tetsuro Ohmori :
両側視床下核深部脳刺激術を施行され左側電極Onによってうつ状態から躁状態に転じたパーキンソン病の一例,
Psychiatria et Neurologia Japonica, Vol.114, No.4, 468, 2012.
30. Masahito Nakataki and Tetsuro Ohmori :
興奮性アミノ酸仮説に基づく統合失調症の薬物療法の試み NMDA受容体フルアゴニスト(グリシン,D-セリン,D-アラニン)の臨床エビデンス,
Rinsyo Seisin Yakuri, Vol.15, No.5, 679-686, 2012.
31. Ryoma Morigaki, Toshitaka Kawarai, Masahito Nakataki, Junichi Iga, Wataru Sako, Yoshifumi Mizobuchi, Shinji Nagahiro, Satoshi Goto and Ryuji Kaji :
Clinical characteristics of X-linked dystonia-parkinsonism,
Functional Neurosurgery, Vol.50, 150-153, 2011.
(CiNii: 1571135651154880768)
32. Kumiko Kikuchi, Junichi Iga, Sumiko Tayoshi, Masahito Nakataki, Shinya Watanabe, Shusuke Numata and Tetsuro Ohmori :
Lithium decreases VEGF mRNA expression in leukocytes of healthy subjects and patients with bipolar disorder.,
Human Psychopharmacology, Vol.26, No.4-5, 358-363, 2011.
(Tokushima University Institutional Repository: 106306,   DOI: 10.1002/hup.1215,   PubMed: 21721043)
33. Masahito Nakataki, Junichi Iga, Shusuke Numata, Eriko Yoshimoto, Kanami Kodera, Shinya Watanabe, Hongwei Song, Shu-ichi Ueno and Tetsuro Ohmori :
Gene expression and association analysis of the epithelial membrane protein 1 gene in major depressive disorder in the Japanese population.,
Neuroscience Letters, Vol.489, No.2, 126-130, 2011.
(DOI: 10.1016/j.neulet.2010.12.001,   PubMed: 21146590)
34. Yoshinori Ueoka, Masahito Tomotake, Tsunehiko Tanaka, Yasuhiro Kaneda, Kyoko Taniguchi, Masahito Nakataki, Shusuke Numata, Shinya Tayoshi, Ken Yamauchi, Satsuki Sumitani, Takashi Ohmori, Shu-ichi Ueno and Tetsuro Ohmori :
Quality of life and cognitive dysfunction in people with schizophrenia,
Progress in Neuro-Psychopharmacology & Biological Psychiatry, Vol.35, No.1, 53-59, 2011.
(DOI: 10.1016/j.pnpbp.2010.08.018,   PubMed: 20804809,   Elsevier: Scopus)
35. Shinya Tayoshi, Masahito Nakataki, Satsuki Sumitani, Kyoko Taniguchi, Sumiko Tayoshi, Shusuke Numata, Junichi Iga, Shu-ichi Ueno, Masafumi Harada and Tetsuro Ohmori :
GABA concentration in schizophrenia patients and the effects of antipsychotic medication: a proton magnetic resonance spectroscopy study.,
Schizophrenia Research, Vol.117, No.1, 83-91, 2010.
(DOI: 10.1016/j.schres.2009.11.011,   PubMed: 20022731)
36. Shusuke Numata, Masahito Nakataki, Junichi Iga, Toshihito Tanahashi, Yoshihiro Nakadoi, Kazutaka Ohi, Ryota Hashimoto, Masatoshi Takeda, Mitsuo Itakura, Shu-ichi Ueno and Tetsuro Ohmori :
Association Study Between the Pericentrin (PCNT) Gene and Schizophrenia.,
NeuroMolecular Medicine, Vol.12, No.3, 243-247, 2009.
(DOI: 10.1007/s12017-009-8106-x,   PubMed: 19937158)
37. Masahito Nakataki, Shusuke Numata, Junichi Iga, Shin'ya Tayoshi, Sumiko Tayoshi-Shibuya, Hongwei Song, Toshihito Tanahashi, Mitsuo Itakura, Shu-ichi Ueno and Tetsuro Ohmori :
No association between Rho-associated coiled-coil forming protein serine/threonine kinase1 gene and schizophrenia in the Japanese population.,
Psychiatric Genetics, Vol.19, No.3, 162, 2009.
(DOI: 10.1097/YPG.0b013e32832a5030,   PubMed: 19404162)
38. Shusuke Numata, Junichi Iga, Masahito Nakataki, Shinya Tayoshi, Kyoko Taniguchi, Satsuki Sumitani, Masahito Tomotake, Toshihito Tanahashi, Mitsuo Itakura, Yoko Kamegaya, Masahiko Tsutsumi, Akira Sano, Takashi Asada, Hiroshi Kunugi, Shu-ichi Ueno and Tetsuro Ohmori :
Gene expression and association analyses of the phosphodiesterase 4B (PDE4B) gene in major depressive disorder in the Japanese population.,
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics, Vol.150B, No.4, 527-534, 2009.
(DOI: 10.1002/ajmg.b.30852,   PubMed: 18785206)
39. Shusuke Numata, Junichi Iga, Masahito Nakataki, Shinya Tayoshi, Toshihito Tanahashi, Mitsuo Itakura, Shu-ichi Ueno and Tetsuro Ohmori :
Positive association of the pericentrin (PCNT) gene with major depressive disorder in the Japanese population.,
Journal of Psychiatry & Neuroscience, Vol.34, No.3, 195-198, 2009.
(PubMed: 19448849)
40. Shin'Ya Tayoshi, Satsuki Sumitani, Kyoko Taniguchi, Sumiko Shibuya-Tayoshi, Shusuke Numata, Jun-ichi Iga, Masahito Nakataki, Shu-ichi Ueno, Masafumi Harada and Tetsuro Ohmori :
Metabolite changes and gender differences in schizophrenia using 3-Tesla proton magnetic resonance spectroscopy (1H-MRS).,
Schizophrenia Research, Vol.108, No.1-3, 69-77, 2008.
(DOI: 10.1016/j.schres.2008.11.014,   PubMed: 19097753)
41. Shusuke Numata, Shu-ichi Ueno, Junichi Iga, Hongwei Song, Masahito Nakataki, Shinya Tayoshi, Satsuki Sumitani, Masahito Tomotake, Mitsuo Itakura, Akira Sano and Tetsuro Ohmori :
Positive association of the PDE4B (phosphodiesterase 4B) gene with schizophrenia in the Japanese population.,
Journal of Psychiatric Research, Vol.43, No.1, 7-12, 2008.
(DOI: 10.1016/j.jpsychires.2008.01.013,   PubMed: 18329668)
42. Shusuke Numata, Shu-ichi Ueno, Junichi Iga, Masahito Nakataki, Toshihito Tanahashi, Mitsuo Itakura, Akira Sano, Kazutaka Ohi, Ryota Hashimoto, Masatoshi Takada and Tetsuro Ohmori :
No association between the NDE1 gene and schizophrenia in the Japanese population.,
Schizophrenia Research, Vol.99, No.1-3, 367-369, 2008.
(DOI: 10.1016/j.schres.2007.10.032,   PubMed: 18178387)
43. Junichi Iga, Shu-ichi Ueno, Ken Yamauchi, Shusuke Numata, Sumiko Tayoshi-Shibuya, Sawako Kinouchi, Masahito Nakataki, Hongwei Song, Kazuhiko Hokoishi, Hirotaka Tanabe, Akira Sano and Tetsuro Ohmori :
The Val66Met polymorphism of the brain-derived neurotrophic factor gene is associated with psychotic feature and suicidal behavior in Japanese major depressive patients,
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics, Vol.144, No.8, 1003-1006, 2007.
(DOI: 10.1002/ajmg.b.30520,   PubMed: 17510948)
44. Hongwei Song, Shu-ichi Ueno, Shusuke Numata, Junichi Iga, Sumiko Tayoshi, Masahito Nakataki, Shin'Ya Tayoshi, Ken Yamauchi, Satsuki Sumitani, Tomohito Tomotake, Tomohito Tada, Toshihito Tanahashi, Mitsuo Itakura and Tetsuro Ohmori :
Association between PNPO and schizophrenia in the Japanese population,
Schizophrenia Research, Vol.97, No.1-3, 264-270, 2007.
(DOI: 10.1016/j.schres.2007.08.004,   PubMed: 17851041)
45. Junichi Iga, Shu-ichi Ueno, Ken Yamauchi, Shusuke Numata, Sumiko Tayoshi, Sawako Kinouchi, Masahito Nakataki, Song Hongwei, Kazuhiko Hokoishi, Hirotaka Tanabe, Akira Sano and Tetsuro Ohmori :
Gene expression and association analysis of vascular endothelial growth factor in major depressive disorder,
Progress in Neuro-Psychopharmacology & Biological Psychiatry, Vol.31, No.3, 658-663, 2007.
(DOI: 10.1016/j.pnpbp.2006.12.011,   PubMed: 17257729)

Academic Paper (Unrefereed Paper):

1. 井上 麻由, 上田 美香, Takashi Kaji, 黒濱 綾子, 田山 正伸, Ryuji Nakagawa, Masahito Nakataki, 橋本 公子, 橋本 直子, 春名 充, Masahiko Maegawa, 松下 由喜代, 宮上 和美, Naoto Yonetani, Minoru Irahara and Mari Haku :
徳島県妊産婦メンタルケア対策 早期発見と支援のポイント(解説),
徳島産婦人科医報, No.52, 130-149, 2019.

Academic Letter:

1. Ryoma Morigaki, Masahito Nakataki, Toshitaka Kawarai, Lillian V. Lee, Rosalia A. Teleg, Ma Daisy P. Tabuena, Hideo Mure, Wataru Sako, Paul Matthew D. Pasco, Shinji Nagahiro, Junichi Iga, Tetsuro Ohmori, Satoshi Goto and Ryuji Kaji :
Depression in X-linked dystonia-parkinsonism:A case-control study,
Parkinsonism & Related Disorders, Vol.19, No.9, 844-846, 2013.
(DOI: 10.1016/j.parkreldis.2013.04.027,   PubMed: 23706616,   Elsevier: Scopus)

Review, Commentary:

1. Masahito Nakataki :
今さら聞けないこの言葉 NMDA受容体,
精神科臨床サービス, Vol.15, No.2, 238-239, 2015.
2. Masahito Nakataki and Tetsuro Ohmori :
Function of glutamate and GABA in schizophrenia,
日本生物学的精神医学会誌, Vol.24, No.3, 145-152, 2013.
(CiNii: 1390282680389196928)
3. Masahito Nakataki and Tetsuro Ohmori :
精神科領域における画像診断の展望 精神疾患とMRS,
最新精神医学, Vol.16, No.3, 303-309, 2011.
4. Masahito Nakataki, Hiroko Kubo, Satsuki Sumitani and Tetsuro Ohmori :
MRSを用いた統合失調症研究,
Japanese Journal of Psychiatric Treatment, Vol.26, No.11, 1427-1433, 2011.
5. Shu-ichi Ueno, Junichi Iga, Shusuke Numata, 宋 鴻偉, Shinya Tayoshi, Masahito Nakataki, Ken Yamauchi and Tetsuro Ohmori :
Genetic aspects of depressive disorder,
Psychiatria et Neurologia Japonica, Vol.109, No.9, 859-863, Sep. 2007.
(CiNii: 1572543025564642304,   Elsevier: Scopus)

Proceeding of International Conference:

1. Tomohiko Nakayama, Hiroaki Edo, Yoshida Tomohiro, Matsumoto Yui, Shinya Watanabe, Masahito Nakataki, Shusuke Numata and Tetsuro Ohmori :
Nortriptyline Therapy of Treatment-Resistant Depression: two case reports,
The CINP 2021 Virtual World Congress, Feb. 2021.
2. Shinya Watanabe, Hidehiro Umehara, Yukiko Tomioka, Makoto Kinoshita, Masahito Nakataki, Shusuke Numata and Tetsuro Ohmori :
Effects of processing conditions on plasma L-glutamate levels in non-psychiatric healthy subjects.,
6th Congress of AsCNP Asian College of Neuropsychopharmacology, Fukuoka, Oct. 2019.
3. Masashi Ohta, Masahito Nakataki, Tomoya Takeda, Shusuke Numata, Takeo Tominaga, Naomi Kameoka, Hiroko Kubo, Makoto Kinoshita, Matsuura Kanae, Maki Ohtomo, Takeichi Naoya, Masafumi Harada and Tetsuro Ohmori :
Causal relationship between salience network dysfunction, depressed mood, and subjective quality of life in schizophrenia.,
6th Congress of AsCNP Asian College of Neuropsychopharmacology, Fukuoka, Oct. 2019.
4. Yukiko Tomioka, Hidehiro Umehara, Shinya Watanabe, Masahito Nakataki, Masuda Rumiko, Kazuaki Mawatari, Takeshi Nikawa, Akira Takahashi, Shusuke Numata and Tetsuro Ohmori :
Altered plasma metabolites related to one-carbon metabolism in schizophrenia.,
WFSBP Asia Pacific Regional Congress of Biological Psychiatry, Kobe, Sep. 2018.
5. Masahito Nakataki :
1H-magnetic resonance spectroscopy study of Glutamate-related abnormality in bipolar disorder,
WFSBP Asia Pacific Regional Congress of Biological Psychiatry, Kobe, Sep. 2018.
6. Tomoya Takeda, Masahito Nakataki, Masashi Ohta, Hamatani Sayo, Matsuura Kanae, Yoshida Reona and Tetsuro Ohmori :
Relationship clinical variables and positive self-thought in patients with schizophrenia.,
The 46th BABCP Annual Workshops and Conference, Glasgow, Scotland., Jul. 2018.
7. Tomoya Takeda, Masahito Nakataki, Masashi Ohta, Hamatani Sayo, Matsuura Kanae and Tetsuro Ohmori :
The effect of negative thoughts on QOL in patients with schizophrenia.,
The 45th BABCP Annual Workshops and Conference, Manchester, Jul. 2017.
8. Masashi Ohta, Y Funakoshi, Masafumi Harada, Junichi Iga, Hiroko Kubo, Masahito Nakataki, C Nakayama, T Nishikawa, Shusuke Numata, Tetsuro Ohmori, Satsuki Sumitani, M Tamaru and A. Uezato :
Structural and functional brain alterations in schizophrenia patients treated with D-cycloserine:a combination of VBM and resting-state functional connectivity study.,
30th CINP World Congress of Neuropsychopharmacology, Seoul, Jul. 2016.
9. Masahito Nakataki, Soravia M. Leila, Schwab Simon, Horn Helge, Dierks Thomas, Strik Werner, Wiest Roland, Heinrichs Markus, Quervain J.-F. de Dominique, Federspiel Andrea and Morishima Yosuke :
Glucocorticoid administration improves aberrant fear processing networks in spider phobia,
CINP 2016, Seoul, Jul. 2016.
10. Tomoya Takeda, Satsuki Sumitani, Masahito Nakataki, Sayo Hamatani, Y Yokose, M Shikata and Tetsuro Ohmori :
Relationship between WAIS- and AQ in Japanese ASD patients with average intelligence quotient.,
31st International Congress of Psychology, Tokyo, Jul. 2016.
11. Masahito Nakataki, M Harada and Tetsuro Ohmori :
Glutamate and GABA concentrations in schizophrenia patients and the effects of antipsychotic medication: results from proton magnetic resonance spectroscopy studies.,
The 3rd Congress of Asian College of Neuropsychopharmacology, China, Sep. 2013.
12. Masahito Nakataki, Satsuki Sumitani, Hiroko Kubo, Shusuke Numata, Junichi Iga, Shinya Watanabe, Makoto Kinoshita, Masafumi Harada and Tetsuro Ohmori :
Structural brain asymmetry in obsessive-compulsive disorder.,
11th world congress of biological psychiatry, Kyoto, Jun. 2013.
13. Masahito Nakataki, Satsuki Sumitani, Hiroko Kubo, Masafumi Harada and Tetsuro Ohmori :
Caudate asymmetry in obesessive compulsive disorder: A voxel based morphometry study,
28th CINP World Congress of Neuropsychopharmacology, Stockholm, Jun. 2012.
14. Masahito Nakataki, Shinya Tayoshi, Hiroko Kubo, Junichi Iga, Shinya Watanabe, Satsuki Sumitani, Masafumi Harada and Tetsuro Ohmori :
Amino acid neurotransmission in schizophrenia patients and the effects of antipsychotic medication: A proton magnetic resonance spectroscopy study,
10th World Conbress of Biological Psychiatry, Prague, Czech Republic, Jun. 2011.
15. Shinya Watanabe, Junichi Iga, Masahito Nakataki, Shusuke Numata, 菊地 久美子 and Tetsuro Ohmori :
Association study of fat-mass and obesity-associated(FTO) gene and body mass index in a Japanese schizophrenia and healthy Japanese population,
10th World Conbress of Biological Psychiatry, Prague, Czech Republic, May 2011.
16. Junichi Iga, 菊地 久美子, Shinya Tayoshi, Masahito Nakataki, Shinya Watanabe, Shusuke Numata and Tetsuro Ohmori :
SOCS3, a candidate gene for the molecular effects of lithium and pathophysiology of MDD,
10th World Conbress of Biological Psychiatry, Prague, Czech Republic, May 2011.
17. 菊地 久美子, Junichi Iga, Shinya Tayoshi, Masahito Nakataki, Shinya Watanabe, Shusuke Numata and Tetsuro Ohmori :
Lithium decreases VEGF mRNA expression in leukocytes of healthy subjects.,
XXVII CINP CONGRESS 2010 WORLD CONGRESS, Hong Kong, Jun. 2010.
18. Junichi Iga, 菊地 久美子, Sumiko Tayoshi, Masahito Nakataki, Shinya Watanabe, Shusuke Numata and Tetsuro Ohmori :
Effect of lithium on gene expression in leukocytes of healthy subjects.,
XXVII CINP CONGRESS 2010 WORLD CONGRESS, Hong Kong, Jun. 2010.
19. Masahito Nakataki, Junichi Iga, Shusuke Numata, E Yoshimoto, K Kodera, Shinya Watanabe, H Song, S Ueno and Tetsuro Ohmori :
Gene expression and association analysis of the epithelial membrane protein 1 gene in major depressive disorder in the Japanese population,
XXVII CINP CONGRESS 2010 WORLD CONGRESS, Hong Kong, Jun. 2010.
20. Shinya Watanabe, Junichi Iga, Masahito Nakataki, Shusuke Numata, Kumiko Kikuchi and Tetsuro Ohmori :
Association study of cannabinoid receptor 1 gene and schizophrenia and body mass index in a Japanese population,
XXVII CINP CONGRESS 2010 WORLD CONGRESS, Hong Kong, Jun. 2010.
21. Yoshinori Ueoka, Masahito Tomotake, Tsunehiko Tanaka, Yasuhiro Kaneda, Masahito Nakataki, Satsuki Sumitani, Shu-ichi Ueno and Tetsuro Ohmori :
Quality of Life and Cognitive Dysfunction in People with Schizophrenia,
The 1st Meeting of the Asian College of Neuropsychopharmacology, Nov. 2009.
22. Masahito Tomotake, Yoshinori Ueoka, Tsunehiko Tanaka, Yasuhiro Kaneda, Ken Yamauchi, Kyoko Taniguchi, Yumiko Takikawa, Masahito Nakataki, Shusuke Numata, Shinya Tayoshi, Satsuki Sumitani, Yumiko Izaki, Takashi Ohmori, Shu-ichi Ueno and Tetsuro Ohmori :
Subjective quality of life and cognitive function in people with schizophrenia,
XIV World Congress of Psychiatry, Sep. 2008.
23. Yoshinori Ueoka, Masahito Tomotake, Tsunehiko Tanaka, Yasuhiro Kaneda, Ken Yamauchi, Kyoko Taniguchi, Yumiko Takikawa, Masahito Nakataki, Shusuke Numata, Shinya Tayoshi, Satsuki Sumitani, Yumiko Izaki, Takashi Ohmori, Shu-ichi Ueno and Tetsuro Ohmori :
Predictors of objective quality of life in people with schizophrenia,
XIV World Congress of Psychiatry, Sep. 2008.
24. Masahito Nakataki, Junichi Iga, Shu-ichi Ueno, K Yamauchi, Shusuke Numata, S Tayoshi-Shibuya, S Kinouhci, H Song, K Hokoishi, H Tanabe, A Sano and Tetsuro Ohmori :
Gene expression and association analysis of vascular endothelial growth factor in major depressive disorder.,
Neuroscience, SanDiego, USA, Nov. 2007.
25. Shusuke Numata, Shu-ichi Ueno, Junichi Iga, Song Hongwei, Masahito Nakataki, Mitsuo Itakura, Akira Sano and Tetsuro Ohmori :
Positive Association of The PDE4B (Phosphodiesterase 4B) gene with Schizophrenia in the Japanese Population,
Neuroscience, San Diego, USA, Nov. 2007.

Proceeding of Domestic Conference:

1. Yoshiteru Tada, Masahito Nakataki, Tatsuo Mori, Toshitaka Fujihara, Aya Gohji, Hiroki Yamazaki, 高尾 里沙, 泉 千恵, 多田 雅美, 安部 修司 and Kenji Mori :
今後の徳島県におけるてんかん地域診療連携整備事業の展望について,
第9回全国てんかんセンター協議会総会, Mar. 2022.
2. Taku Matsuda, Ryoma Morigaki, Yuki Matsumoto, Hideo Mure, Kazuhisa Miyake, Masahito Nakataki, Masafumi Harada and Yasushi Takagi :
全身性ジストニアと強迫性障害の重症度についての検討,
第61回日本定位・機能神経外科学会, Jan. 2022.
3. Ryoma Morigaki, Hideo Mure, Taku Matsuda, Kazuhisa Miyake, Ryosuke Miyamoto, Koji Fujita, Masahito Nakataki, Ryuji Kaji, Yasushi Takagi and Satoshi Goto :
機能ー器質ボーダーラインジストニアに対する脳深部刺激療法,
第60回 日本定位・機能神経外科学会, Jan. 2021.
4. Shusuke Numata, Masahito Nakataki, 長谷川 尚美, Reon Edagawa, Hiroaki Edo, 三浦 健一郎, 松本 純弥, 稲田 健, 渡邊 衡一郎 and 橋本 亮太 :
ガイドラインの理解度向上の取り組み,
第30回日本臨床精神神経薬理学会学術総会, Jan. 2021.
5. Ryosuke Miyamoto, 黒田 一駿, Hideo Mure, Ryoma Morigaki, Masahito Nakataki, Yusuke Osaki, Yuishin Izumi, Satoshi Goto and Ryuji Kaji :
18p-症候群に伴う全身性ジストニアに対し,GPi-DBSが効果的であった一例,
第61回日本神経学会学術大会, Aug. 2020.
6. Shusuke Numata, Masahito Nakataki, 長谷川 尚美, Reon Edagawa, Hiroaki Edo, 三浦 健一郎, 松本 純弥, 稲田 健, 渡邊 衡一郎 and 橋本 亮太 :
統合失調症とうつ病に対する治療ガイドライン教育プロジェクト(EGUIDEプロジェクト)におけるガイドライン理解度向上の取り組みとその結果,
第50回日本神経精神薬理学会年会, Aug. 2020.
7. Yoshiteru Tada, Yoshihiro Touda, Masahito Nakataki, Toshitaka Fujihara, 森 達夫, Aya Gohji, 飯田 幸治, Kenji Mori and Yasushi Takagi :
徳島県におけるてんかん地域診療連携整備事業の活動状況,
第7回全国てんかんセンター協議会広島大会, Feb. 2020.
8. Taku Matsuda, Ryoma Morigaki, Hideo Mure, Masahito Nakataki, 山本 陽子, 豊田 直人, Satoshi Goto and Yasushi Takagi :
ジストニアと強迫性障害の関係についての検討,
Functional Neurosurgery, 130, Jan. 2020.
9. Ryosuke Miyamoto, Koji Fujita, Hideo Mure, Ryoma Morigaki, Masahito Nakataki, Yuishin Izumi, Satoshi Goto and Ryuji Kaji :
ヒステリー性麻痺の臨床診断と電気生理 心因性運動障害の診断 心因性ジストニアを中心に,
第49回日本臨床神経生理学会学術大会, Nov. 2019.
10. Masahito Nakataki, Hiroaki Edo, Yoshiteru Tada, Yoshihiro Touda, Toshitaka Fujihara, Tatsuo Mori, Aya Gohji, Kenji Mori and Tetsuro Ohmori :
てんかん発作や精神症状と関連しない生活の質,
第53回日本てんかん学会学術集会, Nov. 2019.
11. Yoshiteru Tada, Yoshihiro Touda, Masahito Nakataki, Toshitaka Fujihara, Tatsuo Mori, Aya Gohji, 飯田 幸治, Kenji Mori and Yasushi Takagi :
徳島県におけるてんかん地域診療連携整備事業の紹介,
第53回日本てんかん学会学術集会, Oct. 2019.
12. Tomoya Takeda, Masahito Nakataki, Masashi Ohta, 松浦 可苗, 吉田 玲於奈 and Tetsuro Ohmori :
因子分析を用いた統合失調症の神経認知機能と社会認知の検討,
日本心理学会第83回大会, Sep. 2019.
13. Tomohiko Nakayama, Hiroaki Edo, 吉田 朋広, 松本 唯, Shinya Watanabe, Masahito Nakataki, Shusuke Numata and Tetsuro Ohmori :
電気けいれん療法で改善せず,ノルトリプチリンが奏功した反復性うつ病の2症例,
第16回日本うつ病学会総会, Jul. 2019.
14. Hidehiro Umehara, 戸田 裕之, 斎藤 拓, Masahito Nakataki, Shusuke Numata and Tetsuro Ohmori :
うつ病患者における養育環境のDNAメチル化修飾への影響の検討,
第16回日本うつ病学会総会, Jul. 2019.
15. Makoto Kinoshita, Hidehiro Umehara, Shinya Watanabe, Masahito Nakataki, Atsushi Tajima, Shusuke Numata and Tetsuro Ohmori :
統合失調症における網羅的血漿ホモシステイン濃度関連遺伝子同定研究,
第41回日本生物学的精神医学会, Jun. 2019.
16. 青井 駿, Hidehiro Umehara, Aya Gohji, 東田 義広, Shinya Watanabe, Masahito Nakataki, Shusuke Numata and Tetsuro Ohmori :
感冒症状後にチック症状と強迫症状の出現増悪を認め,PANDASが疑われた1例,
第115回日本精神神経学会学術総会, Jun. 2019.
17. Tomohiko Nakayama, 吉田 朋広, Shinya Watanabe, Masahito Nakataki, Shusuke Numata and Tetsuro Ohmori :
治療に難渋し,三環系抗うつ薬で改善がみられた反復性うつ病の1例,
第115回日本精神神経学会学術総会, Jun. 2019.
18. Takeo Tominaga, Shusuke Numata, Masahito Nakataki, Shinya Watanabe, Naomi Kameoka and Tetsuro Ohmori :
徳島大学 精神医学教室の研究:認知機能・QOL,
第115回日本精神神経学会学術総会, Jun. 2019.
19. Yukiko Tomioka, Masahito Nakataki, Hidehiro Umehara, Shinya Watanabe, Shusuke Numata and Tetsuro Ohmori :
統合失調症患者における血清葉酸濃度の検討,
第14回日本統合失調症学会, Apr. 2019.
20. 松浦 可苗, Tomoya Takeda, 吉田 玲於奈, Masahito Nakataki and Tetsuro Ohmori :
徳島大学病院精神科で実施された心理検査の変遷,
日本心理学会第82回大会, Sep. 2018.
21. Masahito Nakataki, Hiroko Kubo, Satsuki Sumitani, Shusuke Numata, Naomi Kameoka, Shinya Watanabe, Hidehiro Umehara, Masashi Ohta, Masafumi Harada and Tetsuro Ohmori :
双極性障害患者におけるアミノ酸系神経伝達物質の異常,
第15回日本うつ病学会総会, Jul. 2018.
22. Masatoshi Inoshita, Hidehiro Umehara, Shinya Watanabe, Masahito Nakataki, Makoto Kinoshita, Yukiko Tomioka, Atsushi Tajima, Shusuke Numata and Tetsuro Ohmori :
うつ病患者の末梢血グルタミン酸濃度のメタ解析,
第15回日本うつ病学会総会, Jul. 2018.
23. Hidehiro Umehara, Shinya Watanabe, Masahito Nakataki, Shusuke Numata and Tetsuro Ohmori :
うつ病の末梢白血球におけるSGK1遺伝子発現,
第15回日本うつ病学会総会, Jul. 2018.
24. Masashi Ohta, Masahito Nakataki, Tomoya Takeda, Shusuke Numata, Takeo Tominaga, Naomi Kameoka, Hiroko Kubo, Makoto Kinoshita, 松浦 可苗, Maki Ohtomo, 武市 直也, Masafumi Harada and Tetsuro Ohmori :
統合失調症におけるSalience Network機能障害,抑うつ気分,および主観的QOLの因果関係.,
第114回日本精神神経学会学術総会, Jun. 2018.
25. Yukiko Tomioka, Shusuke Numata, Makoto Kinoshita, Hidehiro Umehara, Shinya Watanabe, Masahito Nakataki, 岩山 佳美, 豊田 倫子, 池田 匡志, 山森 英長, 下寺 信次, Atsushi Tajima, 橋本 亮太, 岩田 仲生, 吉川 武男 and Tetsuro Ohmori :
血清ピリドキサール(ビタミンB6)と統合失調症の関連研究,
第13回日本統合失調症学会, Mar. 2018.
26. Masashi Ohta, Masahito Nakataki, Satsuki Sumitani, Shusuke Numata, Junichi Iga, Hiroko Kubo, 田丸 麻衣, 中山 千明, 船越 康宏, 上里 彰仁, Masafumi Harada, 西川 徹 and Tetsuro Ohmori :
D-サイクロセリンにより治療された統合失調症患者における脳構造的および機能的結合性変化 VBMと安静時fMRIによるコンビネーション研究.,
第13回日本統合失調症学会, Mar. 2018.
27. Tomoya Takeda, Masahito Nakataki, Masashi Ohta, 濱谷 沙世, 松浦 可苗, 吉田 玲於奈, Naomi Kameoka, Takeo Tominaga, 坂本 新介, Hidehiro Umehara, Makoto Kinoshita, Hiroko Kubo, Shinya Watanabe, Shusuke Numata, Satsuki Sumitani and Tetsuro Ohmori :
統合失調症患者の否定的・肯定的自動思考と臨床要因との関連,
第13回統合失調症学会, Mar. 2018.
28. Hideo Mure, Ryoma Morigaki, Ryosuke Miyamoto, Masahito Nakataki, Yasushi Takagi, Ryuji Kaji, Shinji Nagahiro and Satoshi Goto :
ジストニアDBS治療における多職種連携.,
第57回日本定位・機能神経外科学会, Jan. 2018.
29. Hideo Mure, Ryoma Morigaki, Ryosuke Miyamoto, Masahito Nakataki, 岡久 哲也, Yasushi Takagi, Ryuji Kaji, Shinji Nagahiro and Satoshi Goto :
ジストニアDBS治療における多職種連携,
第57回日本定位・機能神経外科学会, Jan. 2018.
30. Yukio Tada, 宮崎 厚子, 加藤 美玲, 門田 芳, 谷口 早紀, Masahito Nakataki, Naomi Kameoka, Junichi Iga and Tetsuro Ohmori :
がん患者を対象とした心理士による心理相談と,精神科によるリエゾン診療,
第58回中国・四国精神神経学会, Nov. 2017.
31. Hidehiro Umehara, Shinya Watanabe, Makoto Kinoshita, Yukiko Tomioka, Masahito Nakataki, 畠山 豊, 中原 潔, Takeshi Nikawa, Shusuke Numata and Tetsuro Ohmori :
うつ病における血漿グルタミン,グルタミン酸,グルタミン/グルタミン酸比,
第27回日本臨床精神神経薬理学会, Nov. 2017.
32. Hideo Mure, Ryoma Morigaki, Ryosuke Miyamoto, Masahito Nakataki, Junichiro Satomi, Ryuji Kaji, Satoshi Goto and Shinji Nagahiro :
ジストニアDBS治療におけるチーム医療の重要性 -徳島大学での取り組み-,
日本脳神経外科学会 第76回学術総会, Oct. 2017.
33. Masahito Nakataki, Leila M. Soravia, Simon Schwab, Helge Horn, Thomas Dierks, Werner Strik, Roland Wiest, Markus Heinrichs, Dominique J.-F. de Quervain, Andrea Federspiel and 森島 洋介 :
クモ恐怖症患者の恐怖刺激の処理に関与する神経ネットワークにおけるグルココルチコイドの効果,
第39回日本生物学的精神医学会, Sep. 2017.
34. Tomoya Takeda, Masahito Nakataki, Masashi Ohta, 濱谷 沙世, 松浦 可苗 and Tetsuro Ohmori :
統合失調症患者における神経認知機能を媒介した脳灰白質体積とQOLの関連.,
第39回日本生物学的精神医学会, Sep. 2017.
35. 松浦 可苗, 濱谷 沙世, Tomoya Takeda, Masahito Nakataki and Tetsuro Ohmori :
ASD精査目的で行われたWAIS-ⅢとPARS-TRとの関連,
第81回日本心理学会, Sep. 2017.
36. Masatoshi Inoshita, Makoto Kinoshita, Hidehiro Umehara, Masahito Nakataki, Atsushi Tajima, 池田 匡志, 丸山 惣一郎, 山森 英長, 金沢 徹文, 下寺 信次, 橋本 亮太, Issei Imoto, 米田 博, 岩田 仲生, Shusuke Numata and Tetsuro Ohmori :
C-reactive protein and schizophrenia; A Mendelian Randomization approach.,
第12回日本統合失調症学会, Mar. 2017.
37. Hiroko Kubo, Masahito Nakataki, Satsuki Sumitani, Masafumi Harada and Tetsuro Ohmori :
MRSを用いた気分安定薬服用中の双極性障害患者におけるグルタミン酸神経伝達の異常,
第26回日本臨床精神神経薬理学会, Nov. 2016.
38. Masahito Nakataki :
神経回路機能異常 -病態と治療- シンポジウム 恐怖症患者の神経ネットワーク異常とコルチゾール投与による変化,
第59回脳循環代謝学会, Nov. 2016.
39. Masashi Ohta, Masahito Nakataki, Mai Tamaru, Hiroko Kubo, 中山 千明, 船越 康宏, 上里 彰仁, Shusuke Numata, Junichi Iga, Satsuki Sumitani, Masafumi Harada, 西川 徹 and Tetsuro Ohmori :
D-サイクロセリンにより治療された統合失調症患者における内側前頭前皮質の機能的統合安静時fMRI研究,
第46回日本神経精神薬理学会, Jul. 2016.
40. Hiroko Kubo, Masahito Nakataki, Satsuki Sumitani and Tetsuro Ohmori :
MRSによる双極性障害におけるリチウムの作用の検討.,
第24回日本臨床精神神経薬理学会, Nov. 2014.
41. Junichi Iga, Shinya Watanabe, Akira Nishi, Shusuke Numata, Makoto Kinoshita, Kumiko Kikuchi, Masahito Nakataki and Tetsuro Ohmori :
Microarray analysis of the leukocyte global gene expression profile following lithium treatment.,
Neuro 2013(第36回日本神経科学大会・第56回日本神経化学会大会・第23回日本神経回路学会大会, Jun. 2013.
42. Ryoma Morigaki, Masahito Nakataki, Junichi Iga, Toshitaka Kawarai, Hideo Mure, Yoshifumi Mizobuchi, 大北 真哉, Tetsuro Ohmori, Shinji Nagahiro, Satoshi Goto and Ryuji Kaji :
X-linked dystonia-parkinsonismのうつ症状,
第52回日本定位・機能神経外科学会, Jan. 2013.
43. Tetsuro Furumoto, Kojiro Nagai, Satoshi Yamada, Eriko Shibata, Fumi Kishi, Seiji Kishi, Motokazu Matsuura, Akira Mima, Hideharu Abe, Toshio Doi, Risa Takeuchi, Ysuhiro Noda, Seiji Kobayashi, Yusuke Chikata, Aiko Takamatsu, Kanae Yamada, 長江 雄浩 and Masahito Nakataki :
血液透析によってリチウム中毒による意識障害の改善をみた1症例,
第43回徳島透析療法研究会, Nov. 2012.
44. Masahito Nakataki, 渡部 真也, 福間 亮介, Junichi Iga and Tetsuro Ohmori :
クロザピンにより薬剤性ジストニアが改善した2症例,
第22回日本臨床精神神経薬理学会・第42回日本神経精神薬理学会合同年会, Oct. 2012.
45. Junichi Iga, Shinya Watanabe, 西 晃, Shusuke Numata, Makoto Kinoshita, Masahito Nakataki and Tetsuro Ohmori :
白血球遺伝子発現を指標としたリチウムの精神薬理学的研究,
第22回日本臨床精神神経薬理学会, Oct. 2012.
46. Makoto Kinoshita, Masahito Nakataki, Satsuki Sumitani and Tetsuro Ohmori :
片側電極のOn-Offによって躁状態とうつ状態を呈した両側STN-DBSを施行されたパーキンソン病の一例,
第34回日本生物学的精神医学会, Sep. 2012.
47. Masahito Nakataki and Tetsuro Ohmori :
統合失調症患者におけるグルタミン酸・GABAの動態,
第34回日本生物学的精神医学会, Sep. 2012.
48. 福間 亮介, Masahito Nakataki, Junichi Iga and Tetsuro Ohmori :
重篤な遅発性ジストニアを持つ統合失調症患者へclozapineを用いた一例,
第52回中国・四国精神神経学会, Nov. 2011.
49. Makoto Kinoshita, Masahito Nakataki, Satsuki Sumitani and Tetsuro Ohmori :
両側視床下核深部脳刺激術を施行され左側電極Onによってうつ状態から躁状態に転じたパーキンソン病の一例,
第52回中国・四国精神神経学会, Nov. 2011.
50. Masahito Nakataki, Hiroko Kubo, Junichi Iga, Shinya Watanabe, Satsuki Sumitani, Masafumi Harada and Tetsuro Ohmori :
統合失調症患者におけるアミノ酸神経伝達が抗精神病薬から受ける影響 1H-MRS(proton magnetic resonance spectroscopy)を用いた検討,
第21回日本臨床精神神経薬理学会・第41回日本神経精神薬理学会合同年会, Oct. 2011.
51. Junichi Iga, 菊池 久美子, Sumiko Tayoshi, Masahito Nakataki, 渡部 真也, Shusuke Numata and Tetsuro Ohmori :
SOCS3遺伝子はリチウムの作用機序とうつ病の病態における候補遺伝子である,
第21回日本臨床精神神経薬理学会, Oct. 2011.
52. 渡部 真也, Junichi Iga, Masahito Nakataki, Shusuke Numata, 菊地 久美子 and Tetsuro Ohmori :
統合失調症患者と健常対象者におけるFTO遺伝子とbody mass indexとの関連研究,
第21回日本臨床精神神経薬理学会, Oct. 2011.
53. Satsuki Sumitani, Shinya Tayoshi, Masahito Nakataki and Tetsuro Ohmori :
高磁場MRSを用いた非侵襲的脳内代謝物質測定による統合失調症アミノ酸仮説の検討,
第7回統合失調症研究会, Feb. 2011.
54. Masahito Nakataki, Shusuke Numata, Ken Yamauchi, 元木 洋介, 宇山 環奈, 青野 成孝, Takeo Tominaga, Yasuhiro Kaneda and Tetsuro Ohmori :
初発,再発の統合失調症患者におけるアリピプラゾールの有用性の検討 多施設共同臨床研究,
第20回日本臨床精神神経薬理学会, 2010.
55. Shinya Watanabe, Junichi Iga, Masahito Nakataki, Kumiko Kikuchi and Tetsuro Ohmori :
日本人におけるcannabinoid receptor1 遺伝子多型とbody mass index,および統合失語症との関連研究,
第32回日本生物学的精神医学会, Oct. 2010.
56. Masahito Nakataki, Shinya Tayoshi and Tetsuro Ohmori :
画像研究は統合失調症の病態をどこまで明らかにしたか?,
第32回日本生物学的精神医学会, Oct. 2010.
57. Masahito Nakataki and Tetsuro Ohmori :
統合失調症研究におけるMRS,
第32回日本生物学的精神医学会, Oct. 2010.
58. 福田 正人, 高橋 英彦, 岡田 剛, Masahito Nakataki, 滝沢 龍 and 中村 元昭 :
脳画像から見た精神薬理-マクロとミクロの接点,
第20回日本臨床精神神経薬理学会, Sep. 2010.
59. Junichi Iga, 菊地 久美子, Masahito Nakataki, Shinya Watanabe, Shusuke Numata and Tetsuro Ohmori :
Lithium decreases VEGF mRNA expression in leukocytes of healthy subjects and bipolar patients,
第20回日本臨床精神神経薬理学会, Sep. 2010.
60. Yoshinori Ueoka, Masahito Tomotake, Tsunehiko Tanaka, Yasuhiro Kaneda, Masahito Nakataki, Shusuke Numata, Shinya Tayoshi, Satsuki Sumitani, Takashi Ohmori, Shu-ichi Ueno and Tetsuro Ohmori :
Subjective Quality of Life and Cognitive Function in Outpatients with Schizophrenia,
第5回日本統合失調症学会, Mar. 2010.
61. Yoshinori Ueoka, Masahito Tomotake, Tsunehiko Tanaka, Yasuhiro Kaneda, Masahito Nakataki, Satsuki Sumitani, Shu-ichi Ueno and Tetsuro Ohmori :
Quality of Life and Cognitive Dysfunction in People with Schizophrenia,
第19回日本臨床精神神経薬理学会・第39回日本神経精神薬理学会合同年会, Nov. 2009.
62. Masahito Tomotake, Yoshinori Ueoka, Tsunehiko Tanaka, Yasuhiro Kaneda, Ken Yamauchi, Kyoko Taniguchi, Takikawa Yumiko, Masahito Nakataki, Shusuke Numata, Shinya Tayoshi, Satsuki Sumitani, Yumiko Izaki, Takashi Ohmori, Shu-ichi Ueno and Tetsuro Ohmori :
Quality of life and cognitive function in outpatients with schizophrenia,
第18回日本臨床精神神経薬理学会・第38回日本神経精神薬理学会合同年会, Oct. 2008.
63. Yoshinori Ueoka, Masahito Tomotake, Tsunehiko Tanaka, Yasuhiro Kaneda, Masahito Nakataki, Shusuke Numata, Shinya Tayoshi, Satsuki Sumitani, Yumiko Izaki, Takashi Ohmori, Shu-ichi Ueno and Tetsuro Ohmori :
Relationship between cognitive function and clinical factors in people with schizophrenia,
第18回日本臨床精神神経薬理学会・第38回日本神経精神薬理学会合同年会, Oct. 2008.
64. Shusuke Numata, Masahito Nakataki, Junichi Iga, Toshihito Tanahashi, Mitsuo Itakura, Shu-ichi Ueno and Tetsuro Ohmori :
日本人におけるうつ病患者のPCNT2遺伝子関連解析,
第30回日本生物学的精神医学会, Sep. 2008.
65. Masahito Nakataki, Shu-ichi Ueno, Shusuke Numata, Junichi Iga, Shinya Tayoshi, Sumiko Tayoshi, 宋 鴻偉, Toshihito Tanahashi, Mitsuo Itakura and Tetsuro Ohmori :
統合失調症とRho-associated coiled-coil forming protein serine/threonine kinase1遺伝子の関連解析,
第30回日本生物学的精神医学会, Sep. 2008.
66. Shusuke Numata, Junichi Iga, Shu-ichi Ueno, Ken Yamauchi, Hongwei Song, Sumiko Tayoshi, Shinya Tayoshi, Masahito Nakataki, Ryota Hashimoto, Masatoshi Takeda, Hiroshi Kunugi and Tetsuro Ohmori :
Differential expression of Disrupted-In-Schizophrenia-1 (DISC1) in the peripheral leukocytes from schizophrenia and major depressive disorder,
The 2nd Annual Meeting of Japanse Society of Schizophrenia Research, Mar. 2007.

Products:

1. Masahito Nakataki :
精神疾患と自殺予防,
めんたるへるす, No.68, 6-10, Feb. 2020.

Et cetera, Workshop:

1. Tomohiko Nakayama, Hidehiro Umehara, Yukiko Tomioka, 上敷領 俊晴, 淵上 学, 岡田 剛, 増田 瑠見子, Kazuaki Mawatari, Masahito Nakataki, Shusuke Numata, Akira Takahashi, 岡本 泰昌 and Tetsuro Ohmori :
うつ病におけるキヌレニン経路の変化,
第12回脳科学クラスターミニリトリート, Feb. 2021.
2. Tomohiko Nakayama, Hidehiro Umehara, Yukiko Tomioka, 上敷領 俊晴, 淵上 学, 岡田 剛, 増田 瑠見子, Kazuaki Mawatari, Masahito Nakataki, Shusuke Numata, Akira Takahashi, 岡本 泰昌 and Tetsuro Ohmori :
うつ病におけるキヌレニン経路の変化,
第5回メタボロームシンポジウム, Dec. 2020.
3. Tomoya Takeda, Masahito Nakataki, Masashi Ohta and Tetsuro Ohmori :
統合失調症患者における結論への飛躍バイアスと神経認知,社会認知との関連,
第10回脳科学クラスター・ミニリトリート, Feb. 2019.
4. Tomoya Takeda, Masahito Nakataki, Masashi Ohta and Tetsuro Ohmori :
統合失調症患者における自己に関する認知と主観的・客観的QOLとの関連.,
第18回精神疾患と認知機能研究会, Nov. 2018.
5. 武田 知也, Masahito Nakataki, Masashi Ohta, 濱谷 沙世, 松浦 可苗, 吉田 玲於奈, Naomi Kameoka, Takeo Tominaga, 坂本 新介, Hidehiro Umehara, Makoto Kinoshita, Hiroko Kubo, Shinya Watanabe, Shusuke Numata, Satsuki Sumitani and Tetsuro Ohmori :
統合失調症患者における神経認知機能と否定的・肯定的認知の関連.,
第4回CEPD会, Mar. 2018.
6. Tomoya Takeda, Masahito Nakataki, Masashi Ohta, 濱谷 沙世, 松浦 可苗 and Tetsuro Ohmori :
Jumping to conclusionバイアスと認知機能との関連,
第17回精神疾患と認知機能研究会, Nov. 2017.
7. Hidehiro Umehara, Shinya Watanabe, Makoto Kinoshita, Yukiko Tomioka, Masahito Nakataki, 畠山 豊, 中原 潔, Takeshi Nikawa, Shusuke Numata and Tetsuro Ohmori :
うつ病のメタボローム解析,
第2回メタボローム解析シンポジウム, Jun. 2017.
8. Tomoya Takeda, Masahito Nakataki, Masashi Ohta, Sayo Hamatani and Tetsuro Ohmori :
結論への飛躍バイアスや決断への自信と認知機能との関連,
第3回CEPD研究会, Mar. 2017.
9. Shusuke Numata, Masahito Nakataki, Junichi Iga, Shinya Tayoshi, 谷口 京子, Satsuki Sumitani, Masahito Tomotake and 他 :
大うつ病の末梢白血球におけるPDE4B遺伝子の発現と関連研究,
第41回精神神経系薬物治療研究報告会, Dec. 2008.

Grants-in-Aid for Scientific Research (KAKEN Grants Database @ NII.ac.jp)